Replies to post #12614 on DNAprint Genomics (DNAG)

[mingwan0]

mjam, I saw your mail which was interesting. It does beg the question of what this PR was all about:

http://www.dnaprint.com/pr_3_6_03.htm

DNAPrint genomics Partners With GeneLink to Develop 'Next Generation' Genetic-Profile Tests for Personalized Cosmetics
Thursday March 6, 11:12 am ET

SARASOTA, Fla., March 6 /PRNewswire-FirstCall/ -- DNAPrint (OTC Bulletin Board: DNAP - News; the "Company"), the world leader in the measurement of population structure for disease genetics, personalized medicine, recreational genomics and forensics profiling, announced today that it has entered into a collaborative agreement with GeneLink (OTC Bulletin Board: GNLK - News) to develop new genetic assessments for a personalization of cosmetics and personal care product marketing. The agreement also names DNAPrint as GeneLink's genotyping partner. Further details were not disclosed.
The parties intend to develop tests that will be used to assess genetic risks for certain common skin deficiencies. The test results are expected to provide a basis for recommending formulations that have been specifically designed to compensate for these deficiencies. Rather than merely marketing a genetic test, DNAPrint will assist GeneLink and its partners, which include Arch Chemical (http://www.bankdna.com/news_articles/02_11_03.asp ), in focusing on offering a preventative solution for certain common dermatological and skin aging problems. The system would be marketed as part of an individualized precautionary health regimen, and offered for sale by distributors and manufactures to the $100 billion plus cosmetics and personal care industry.

DNAPrint's brings its ultra high throughput genotype capability and ADMIXMAP platform to the partnership while GeneLink brings existing tests and methodologies. The companies intend to screen millions of candidate markers and broaden proprietary product offerings.

About the test

Through the expression of certain genes, skin defends itself from photo- aging and from oxidative stress that is caused by certain common, potentially harmful molecules known as free radicals. Other genetic defense measures catalyze the detoxification of certain harmful environmental pollutants and some actually cause mild irritation that results from exposure to common products used in daily living (such as soaps). Though all humans have built-in genetic defense mechanisms, the skin for some people is more adept at certain defenses than for others, and this variability in defensive capability is rooted in the genes. GeneLink's Dermagenetics(TM) assessment measures these genes for individual customers by reading key gene variant sequences called Single Nucleotide Polymorphisms (SNPs). The SNPs are known from decades of public and privately funded research to be associated with accelerated skin aging, skin wrinkling and other specific oxidative stress deficiencies in the skin.

End of PR

Ultimately whether it is a one-off or recurring use of genotyping services or something else is not that important IMO as this is not one of our stated target markets. I always personally put the Genelink initiative in the same category as CMIH. If we see the money fine, but until then...